Michael Hadley: SCOT-HEART 2 Trail Could Transform How We Think About Identifying Those at Risk of Heart Attacks
Michael Hadley, System Director of Advanced Cardiac Imaging at Northwell Health, shared on LinkedIn:
”The SCOT-HEART 2 trail could transform how we think about identifying those at risk of heart attacks.
This ongoing study is randomizing asymptomatic individuals ages 40-70 with 1 or more risk factors for heart disease to either Coronary CTA or standard care, with appropriate therapies, and following for a primary outcome of heart attack.
If the trial is positive, guidelines could recommend broader CT screening of asymptomatic adults, allowing us to detect and treat coronary disease earlier to prevent more heart attacks.
To prepare, we need to model out what a positive trial could mean for patient volumes and what it would take to meet that need.”
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country
-
Dec 16, 2025, 11:03Matías J Alet on CABOS Project with The Support of WSO
-
Dec 16, 2025, 00:32New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
-
Dec 15, 2025, 23:36In a Time of Crisis: Dr. Amanda Rischbieth on Blood Donation, Solidarity, and Saving Lives